You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TLR9

Showing 1 - 25 of 678
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mild Cognitive Impairment, Alzheimer Dementia Trial (CpG1018, Placebo)

Not yet recruiting
  • Mild Cognitive Impairment
  • Alzheimer Dementia
  • (no location specified)
Jan 3, 2023

Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])

Withdrawn
  • Hepatitis B
  • Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
  • Baltimore, Maryland
  • +1 more
Jul 19, 2022

Melanoma Trial in Pittsburgh (drug, biological, other)

Recruiting
  • Melanoma
  • Vidutolimod (CMP-001)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 25, 2022

Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Palo Alto (Ibrutinib, Radiation

Active, not recruiting
  • Grade 1 Follicular Lymphoma
  • +6 more
  • Palo Alto, California
    Stanford University, School of Medicine
Jun 13, 2022

B-Cell Non-Hodgkin Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma Trial in Palo Alto (biological, other,

Active, not recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Anti-OX40 Antibody BMS 986178
  • +3 more
  • Palo Alto, California
    Stanford University, School of Medicine
May 3, 2022

HIV-1-infection Trial in Worldwide (Saline, Lefitolimod, 3BNC117 and 10-1074)

Active, not recruiting
  • HIV-1-infection
  • Salt Lake City, Utah
  • +7 more
Mar 30, 2022

Advanced Malignant Solid Tumor, Extracranial Solid Tumor, Metastatic Malignant Solid Tumor Trial in Palo Alto (Anti-OX40

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Anti-OX40 Antibody BMS 986178
  • TLR9 Agonist SD-101
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
Jun 13, 2022

Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Atlanta (VLP-encapsulated TLR9 Agonist CMP-001,,

Not yet recruiting
  • Metastatic Prostate Adenocarcinoma
  • Stage IV Prostate Cancer AJCC v8
  • VLP-encapsulated TLR9 Agonist CMP-001,
  • Nivolumab
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 26, 2022

Locally Advanced Malignant Solid Tumor, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United

Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +3 more
  • Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949
  • VLP-encapsulated TLR9 Agonist CMP-001
  • Scottsdale, Arizona
  • +3 more
Jun 1, 2022

Melanoma, Lymph Node Cancer Trial in Pittsburgh (CMP-001, Nivolumab)

Active, not recruiting
Has Results
  • Melanoma
  • Lymph Node Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 15, 2022

Advanced Cancer Trial in Villejuif (Ipilimumab, Nivolumab, Tilsotolimod)

Active, not recruiting
  • Advanced Cancer
  • Villejuif, Val De Marne, France
    Gustave Roussy
Jul 21, 2021

Myeloid Malignancies, Lymphoid Malignancies Trial in Durham (NK Cell enriched-DLI only, NK-DLI + DUK-CPG-001)

Recruiting
  • Myeloid Malignancies
  • Lymphoid Malignancies
  • NK Cell enriched-DLI only
  • NK-DLI + DUK-CPG-001
  • Durham, North Carolina
    Duke University Health System
Mar 8, 2022

HIV/AIDS Trial in San Francisco (Combination Intervention)

Active, not recruiting
  • HIV/AIDS
  • Combination Intervention
  • San Francisco, California
    Zuckerberg San Francisco General Hospital, University of Califor
Mar 21, 2022

Metastatic Uveal Melanoma in the Liver Trial in United States (SD-101, Nivolumab, Ipilimumab)

Recruiting
  • Metastatic Uveal Melanoma in the Liver
  • Los Angeles, California
  • +9 more
Jan 27, 2023

Metastatic Pancreatic Adenocarcinoma, Refractory Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +2 more
  • Nivolumab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Dec 16, 2021

Asthma Trial in Germany, United Kingdom (GSK2245035 Nasal Spray Solution, Placebo Nasal Spray Solution)

Completed
Has Results
  • Asthma
  • GSK2245035 Nasal Spray Solution
  • Placebo Nasal Spray Solution
  • Frankfurt, Hessen, Germany
  • +5 more
Feb 26, 2021

Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders

Completed
  • HIV Infections
  • +2 more
    • Baltimore, Maryland
    • +1 more
    Mar 17, 2023

    COVID-19 Trial in Milwaukee (Lactobacillus Plantarum 299v in fermented oat drink, Heat-Killed Placebo control fermented drink)

    Recruiting
    • COVID-19
    • Lactobacillus Plantarum 299v in fermented oat drink
    • Heat-Killed Placebo control fermented drink
    • Milwaukee, Wisconsin
      Medical College of Wisconsin
    Jun 22, 2022

    Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Houston (SD-101, Pembrolizumab, Nivolumab)

    Recruiting
    • Hepatocellular Carcinoma
    • Intrahepatic Cholangiocarcinoma
    • New York, New York
    • +3 more
    Oct 19, 2022

    MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Stanford (biological, drug, radiation)

    Completed
    Has Results
    • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
    • +6 more
    • Ipilimumab
    • +2 more
    • Stanford, California
      Stanford University Hospitals and Clinics
    Nov 17, 2019

    Chronic Hepatitis C Trial in Poland (SD-101, ribavirin)

    Completed
    • Chronic Hepatitis C
    • Bydgoszcz, Poland
    • +4 more
    Apr 11, 2019

    Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Tucson (Tadalafil 20 MG)

    Not yet recruiting
    • Gastric Adenocarcinoma
    • Gastroesophageal Junction Adenocarcinoma
    • Tadalafil 20 MG
    • Tucson, Arizona
      Arizona Cancer Center at UMC North/University Medical Center
    Feb 1, 2023

    Primary Ovarian Insufficiency, Cardiovascular Diseases, Menopause, Premature Trial in Ryazan (Taking a person's venous blood)

    Active, not recruiting
    • Primary Ovarian Insufficiency
    • +6 more
    • Taking a person's venous blood
    • Ryazan, Ryazan Region, Russian Federation
      Sergey Vladimirovich Lopukhov
    Aug 3, 2022

    MicroRNAs and Cytokines in Peri-Implantitis Tissue

    Active, not recruiting
    • Peri-implantitis
      • Baghdad, Iraq
        Munir
      Mar 14, 2023

      Prostatic Tumors Trial in San Francisco (Pembrolizumab, SD-101, Leuprolide acetate)

      Active, not recruiting
      • Prostatic Neoplasms
      • San Francisco, California
        University of California San Francisco
      Sep 20, 2022